BBlogFlow

Saddle Lake health and harvest fair showcases support resources in the community - LakelandToday.ca

·Oct 8, 2026
Source: LakelandToday.ca
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. LakelandToday.ca

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Tickets now on sale for Wetaskiwin Health Foundation’s final Harvest Barn Dance - Pipestone Flyer

Earlier this month, the Wetaskiwin Health Foundation (WHF) opened ticket sales for ‘The Final Harvest Barn Dance,’ set for Saturday, Nov’.14, at Co-op Place. Marking the 19th and final chapter of the annual tradition, the foundation is inviting neighbours, long-time attendees, and new friends alike to gather for one last night of celebration, storytelling, and community impact.

Pipestone Flyer·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·